LED Medical Diagnostics Inc.
TSX VENTURE : LMD
OTCQX : LEDIF
FRANKFURT : LME

LED Medical Diagnostics Inc.

April 15, 2014 09:00 ET

LED Medical Announces New Dealer Agreement Between Subsidiary LED Dental and Two Distributors in Southeast Region of US

BURNABY, BRITISH COLUMBIA--(Marketwired - April 15, 2014) - LED Medical Diagnostics Inc. ("LED Medical" or the "Company") (TSX VENTURE:LMD)(OTCQX:LEDIF)(FRANKFURT:LME) is pleased to announce that its wholly-owned US operating subsidiary, LED Dental Ltd. ("LED Dental") has entered into non-exclusive partnerships with Atlanta Dental Supply Company ("Atlanta Dental") and Nashville Dental, Inc. ("Nashville Dental") for distribution of the Company's VELscope® Vx Enhanced Oral Assessment System and product line within the United States market.

"It is an honor to partner with both Atlanta Dental and Nashville Dental for distribution within the Southeast," said Lamar Roberts, president of LED Dental. "Both of these dealers have extensive networks that will maximize the potential for the VELscope® Vx product line while providing cutting-edge technology to their customers."

"We are excited to offer the market-leading adjunctive oral mucosal examination tool to our client base," said Todd Brown, vice president of equipment for Nashville Dental, Inc. "The VELscope® Vx is saving lives by discovering a wide range of oral abnormalities, including oral cancer, sooner. This technology is in high-demand in the dental industry, and we're proud to add it to our portfolio."

Use of the VELscope® Vx aids in the detection of an array of oral abnormalities, often before they become apparent to the unassisted eye. It is also the only tissue fluorescence device with photo/video documentation capabilities through the viewing mechanism, a key function for referrals and patient records. The device's distinctive blue-spectrum light causes the soft tissues of the mouth to naturally fluoresce. Healthy tissues appear in distinct patterns that are visibly disrupted by trauma or disease, such as neoplastic lesions, chemical irritation, side-effects from medication, thermal damage, as well as fungal, viral or bacterial infections.

"We support the VELscope® Vx as an important, potentially life-saving device," said Tom Richardson, vice president of sales for Atlanta Dental. "LED Dental has established itself as the market leader for tissue fluorescence visualization, and we're proud to partner with them. The VELscope® Vx is a welcome addition to our portfolio of outstanding equipment."

The VELscope® Vx product line will be represented in five states through Atlanta Dental's team of 160 employees and five states through Nashville Dental's team of 108 employees. Today, VELscope® systems are used to conduct more examinations for oral cancer and other oral diseases than any other adjunctive device. To date, more than 13,000 VELscope® Vx systems are in use globally, and dental practitioners have performed more than 25 million exams with the technology.

"Atlanta Dental and Nashville Dental are companies whose core values of innovation, teamwork and service embody our own," said Dr. David Gane, CEO of LED Medical Diagnostics Inc. "They are the true pioneers of dental supply sales in the Southeast region of the U.S., and their clientele has been well served by them for generations. Having a partner who is entrenched within the communities they serve and who continues to increase their service levels and product offerings is exactly the type of relationship we were seeking for expansion of the VELscope® market."

About Atlanta Dental Supply Company

Atlanta Dental is a 100-percent employee-owned, full service distributor of dental supplies, equipment, software and technology, backed by uncompromised service and support. Office design and practice management services are also available. Atlanta Dental offers "breeze" in-office ordering software and exceptional value on all products and services. For more information on Atlanta Dental, visit www.atlantadental.com.

About Nashville Dental, Inc.

Nashville Dental is a family-owned and operated dental supply company founded in 1897 in Nashville, Tennessee. The company has a long history of partnership with dental practices, offering comprehensive product and service packages for new, established and retiring dental offices. Nashville Dental operates out of eight locations throughout Tennessee, Kentucky, Alabama, and West Virginia. For more information on Nashville Dental, visit www.nashvilledental.com.

About LED Dental Ltd.

Based in Atlanta, Ga., LED Dental Ltd. is a wholly-owned US subsidiary of LED Medical Diagnostics Inc. Backed by an experienced leadership team dedicated to a higher level of service and support, LED Dental offers advanced diagnostic imaging equipment that seamlessly integrates into dental practices. The Company is committed to providing dental practitioners with the best technology available by identifying and adding strong products to its growing portfolio. Additionally, the company manufactures the award-winning VELscope® Vx Enhanced Oral Assessment System, the first system in the world to apply tissue fluorescence visualization technology to the oral cavity. Available through major dental supply distributors, the VELscope® Vx is used to conduct more screenings for oral cancer and other oral diseases than any other adjunctive device. For more information, call 888.541.4614 or visit www.leddental.com.

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc. is a leading developer of LED‐based visualization technologies for the medical industry. The Company is currently listed on the Toronto Stock Exchange (TSX‐V) under the symbol "LMD," the OTCQX under the symbol "LEDIF," as well as the Frankfurt Stock Exchange under the symbol "LME." For more information, visit www.ledmd.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company's future growth strategy for the United States, its distribution strategy and product offerings, potential expansion of the Company's technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2012. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Contact Information